Abstract
Autism contains a spectrum of behavioral and cognitive disturbances of childhood development that is manifested by deficits in social interaction, impaired communication, repetitive behavior, and/or restricted interest. Much research has been dedicated to finding the genes that are responsible for autism, but less than 10% of the cases can be attributed to one gene. Autism prevalence has increased in the last decade and there may be environmental components that are leading to this increase. There are reports of disruption of epigenetic mechanisms controlling the regulation of gene expression as probable cause for autism. Folic acid (FA) is prescribed to women during pregnancy, and can cause epigenetic changes. GABAergic pathway is involved in inhibitory neurotransmission in the central nervous system and plays a crucial role during early embryonic development. Autism may entail defect or deregulation of the GABAergic receptor pathway in the brain. Gamma-aminobutyric acid (type A) beta 1 receptor (GABRB1) disruption has been implicated in autism. In the present study, we investigated GABRB1 expression in response to FA supplementation in neuronal cells. Western blot analysis showed GABRB1 protein levels increased in the FA-treated cells in a concentration-dependent manner. FA-dependent increased expression of GABRB1 was further confirmed at the mRNA level using quantitative RT-PCR. These results suggest that epigenetic control of gene expression may affect the expression of GABRB1 and disrupt inhibitory synaptic transmission during embryonic development.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- GABRB1:
-
Gamma-aminobutyric acid type A receptor beta 1 subunit
- GABAA :
-
Gamma-aminobutyric acid type A receptors
- FA:
-
Folic acid
- GAD:
-
Glutamic acid decarboxylase
References
Beard CM, Panser LA, Katusic SK (2011) Is excess folic acid supplementation a risk factor for autism? Med Hypotheses 77(1):15–17
Bekkers MB, Elstgeest LE, Scholtens S, Haveman-Nies A, de Jongste JC, Kerkhof M, Koppelman GH, Gehring U, Smit HA, Wijga AH (2012) Maternal use of folic acid supplements during pregnancy, and childhood respiratory health and atopy. Eur Respir J 39(6):1468–1474
Fatemi SH, Reutiman TJ, Folsom TD, Rooney RJ, Patel DH, Thuras PD (2010) mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism. J Autism Dev Disord 40(6):743–750
Huang ZJ, Di Cristo G, Ango F (2007) Development of GABA innervation in the cerebral and cerebellar cortices. Nat Rev Neurosci 8:673–686
Junaid MA, Kuizon S, Cardona J, Azher T, Murakami N, Pullarkat RK, Brown WT (2011) Folic acid supplementation dysregulates gene expression in lymphoblastoid cells -implications in nutrition. Biochem Biophys Res Commun 412(4):688–692
Kuizon S, DiMaiuta K, Walus M, Jenkins EC Jr, Kuizon M, Kida E, Golabek AA, Espinoza DO, Pullarkat RK, Junaid MA (2010) A critical tryptophan and Ca2+ in activation and catalysis of TPPI, the enzyme deficient in classic late-infantile neuronal ceroid lipofuscinosis. PLoS One 5(8):e11929
McLennan Y, Polussa J, Tassone F, Hagerman R (2011) Fragile x syndrome. Curr Genomics 12(3): 216–224
MMWR (1992) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Wkly Rep 41:1–7
Olsen RW, Sieghart W (2009) GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56(1):141–148
Pfeiffer CM, Fazili Z, McCoy L, Zhang M, Gunter EW (2004) Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin Chem 50:423–432
U.S. Preventive Services Task Force (2009) Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 150:626–632
Wolff T, Witkop CT, Miller T, Syed SB, U.S. Preventive Services Task Force (2009) Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 150(9):632–639
Zhang A, Shen CH, Ma SY, Ke Y, El Idrissi A (2009) Altered expression of Autism-associated genes in the brain of Fragile X mouse model. Biochem Biophys Res Commun 379(4):920–923
Acknowledgments
This study is supported by funds from the New York State Office for People with Developmental Disabilities, The City University of New York, The College of Staten Island, and Louis Stokes Alliance for Minority Participation a division of National Science Foundation (NSF). Financial assistance to Kizzy Vasquez is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Vasquez, K., Kuizon, S., Junaid, M., Idrissi, A.E. (2013). The Effect of Folic Acid on GABAA-B 1 Receptor Subunit. In: El Idrissi, A., L'Amoreaux, W. (eds) Taurine 8. Advances in Experimental Medicine and Biology, vol 775. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6130-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6130-2_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6129-6
Online ISBN: 978-1-4614-6130-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)